drugset / Trial / NCT04913519
A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Multi-center, fixed volume, randomized, double-blind, vehicle-controlled, parallel group, dose escalation comparison study of TDM-105795 in male subjects, 18 to 55 years old, with Androgenetic Alopecia (AGA).
Timeline
- Start
- 2021-04-27
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TDM-105795 | Unknown | 0.0025 % | Topical |
| Subject | TDM-105795 | Unknown | 0.005 % | Topical |
| Subject | TDM-105795 | Unknown | 0.01 % | Topical |